Elkfork Partners’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Elkfork Partners’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-16,490	Closed	-$889K	–	1046
2017 Q4	$889K	Buy	16,490 +3,536	+27%	+$193K	0.02%	389
2017 Q3	$739K	Sell	12,954 -3,910	-23%	-$229K	0.02%	390
2017 Q2	$1.01M	Buy	16,864 +10,540	+167%	+$600K	0.03%	328
2017 Q1	$344K	Buy	+6,324	New	+$312K	0.01%	517

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Elkfork Partners's BIVV Position: Q1 2018 in Review

Elkfork Partners sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 16,490 shares — an estimated $889K sold.

Elkfork Partners first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.01M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Elkfork Partners reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Elkfork Partners sold 16,490 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $889K.
Elkfork Partners first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Elkfork Partners's Bioverativ Inc. Common Stock position peaked at $1.01M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Elkfork Partners's 13F filing for Q1 2018, filed 10 May 2018.